Rendering

Component: (Network and Table)
Network
100290 - Disclosure - Share-Based Payment (Tables)
(http://www.alliancehealthcareservices-us.com/20161231/taxonomy/role/DisclosureShareBasedPaymentTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Share Based Compensation [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Share Based Compensation [Abstract]
 
Weighted Average Assumptions For Stock Option Awards

The following weighted average assumptions were used in the estimated grant date fair value calculations for stock option awards:

 

 

 

Year Ended December 31,

 

 

 

2016

 

 

2015

 

 

2014

 

Risk free interest rate

 

 

1.53

%

 

 

1.65

%

 

 

1.83

%

Expected dividend yield

 

 

%

 

 

%

 

 

%

Expected stock price volatility

 

 

66.5

%

 

 

65.2

%

 

 

66.3

%

Average expected life (in years)

 

 

6.0

 

 

 

6.0

 

 

 

6.0

 

Weighted average grant date fair value

 

$

4.32

 

 

$

14.25

 

 

$

17.56

 

 

 
 
Summary of Stock Option Activity

The following table summarizes the Company’s stock option activity:

 

(dollars in thousands except per share amounts)

 

Number of

Shares

 

 

Weighted

Average

Exercise Price

 

 

Weighted

Average

Remaining

Contractual

Term

(in years)

 

 

Aggregate

Intrinsic

Value (1)

 

Outstanding at December 31, 2015

 

 

646,290

 

 

$

19.91

 

 

 

 

 

 

 

 

 

Granted

 

 

200,388

 

 

$

7.16

 

 

 

 

 

 

 

 

 

Exercised

 

 

(121,667

)

 

$

5.05

 

 

 

 

 

 

 

 

 

Canceled/forfeited

 

 

(74,042

)

 

$

22.08

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2016

 

 

650,969

 

 

$

18.51

 

 

 

6.4

 

 

$

917

 

Vested and expected to vest in the future at December 31, 2016

 

 

612,122

 

 

$

19.23

 

 

 

6.2

 

 

$

823

 

Vested and exercisable at December 31, 2016

 

 

463,165

 

 

$

23.11

 

 

 

5.2

 

 

$

462

 

(1)

Represents the difference between the exercise price and the value of the Company’s stock at fiscal year-end.

 
 
Summary of Stock Options By Exercise Price Range

The following table summarizes information of the stock options outstanding and exercisable at December 31, 2016:

 

 

 

Stock Options Outstanding

 

 

Stock Options Exercisable

 

Exercise Price

Range

 

Number of Shares

 

 

Weighted Average

Exercise Price

 

 

Remaining

Contractual Term

(in years)

 

 

Number of Shares

 

 

Weighted Average

Exercise Price

 

 

Remaining

Contractual Term

(in years)

 

$5.70 — $6.29

 

 

127,002

 

 

$

5.96

 

 

 

5.0

 

 

 

127,002

 

 

$

5.96

 

 

 

5.0

 

$6.30 — $6.93

 

 

145,804

 

 

$

6.93

 

 

 

9.2

 

 

 

 

 

$

 

 

 

 

$6.94 — $22.43

 

 

67,287

 

 

$

9.79

 

 

 

8.1

 

 

 

25,287

 

 

$

12.70

 

 

 

6.4

 

$22.44 — $28.46

 

 

67,609

 

 

$

24.01

 

 

 

8.1

 

 

 

67,609

 

 

$

24.01

 

 

 

8.1

 

$28.47 — $28.92

 

 

58,815

 

 

$

28.61

 

 

 

4.6

 

 

 

58,815

 

 

$

28.61

 

 

 

4.6

 

$28.93 — $30.27

 

 

102,952

 

 

$

29.14

 

 

 

6.7

 

 

 

102,952

 

 

$

29.14

 

 

 

6.7

 

$30.28 — $46.30

 

 

81,500

 

 

$

40.72

 

 

 

1.3

 

 

 

81,500

 

 

$

40.72

 

 

 

1.3

 

$5.70 — $46.30

 

 

650,969

 

 

$

18.52

 

 

 

6.4

 

 

 

463,165

 

 

$

23.11

 

 

 

5.2

 

 

 
 
Summary of Unvested Stock Option Activity

The following table summarizes the Company’s unvested stock option activity:

 

(dollars in thousands except per share amounts)

 

Number of Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

Aggregate Unrecognized Compensation(1)

 

 

Weighted Average

Period Over Which

Expected to be

Recognized

(in years)

 

Unvested at December 31, 2015

 

 

158,671

 

 

$

15.01

 

 

 

 

 

 

 

 

 

Granted

 

 

200,388

 

 

$

4.32

 

 

 

 

 

 

 

 

 

Vested

 

 

(156,171

)

 

$

15.05

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(15,084

)

 

$

5.60

 

 

 

 

 

 

 

 

 

Unvested at December 31, 2016

 

 

187,804

 

 

$

4.33

 

 

$

476

 

 

 

2.2

 

 

(1)

The valuation model applied in this calculation utilizes highly subjective assumptions that could potentially change over time, including the expected forfeiture rate and performance targets. Therefore, the amount of unrecognized share-based payment noted above does not necessarily represent the value that will ultimately be realized by the Company in the consolidated statements of income and comprehensive income.

 
 
Summary of Unvested RSU Activity

The following table summarizes the Company’s RSU activity:

 

(dollars in thousands except per share amounts)

 

Shares

 

 

Weighted

Average

Grant Date

Fair Value

 

 

Aggregate Unrecognized Compensation

 

 

Weighted Average

Period Over Which

Expected to be

Recognized

(in years)

 

Unvested at December 31, 2015

 

 

74,413

 

 

 

9.18

 

 

 

 

 

 

 

 

 

Granted

 

 

175,441

 

 

 

8.30

 

 

 

 

 

 

 

 

 

Vested

 

 

(74,413

)

 

 

9.18

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(7,588

)

 

 

6.93

 

 

 

 

 

 

 

 

 

Unvested at December 31, 2016

 

 

167,853

 

 

$

8.37

 

 

$

1,182

 

 

 

1.3

 

 

 
 
Summary of Share-based Compensation Expense

The impact of recording share-based compensation expense in the consolidated statements of income and comprehensive income is summarized below:

 

 

 

Year Ended December 31,

 

(in thousands)

 

2016(1)

 

 

2015

 

 

2014

 

Share-based compensation expense(2)

 

$

3,176

 

 

$

1,701

 

 

$

1,515

 

Income tax benefit

 

 

(936

)

 

 

(595

)

 

 

(540

)

Total share-based compensation expense after income taxes

 

$

2,240

 

 

$

1,106

 

 

$

975

 

 

 

(1)

Includes Cash Right of $463.

 

(2)

Included in “Selling, general and administrative expenses” in the Company’s consolidated statement of income and comprehensive income.